Response to Comments: MolDX-CDD: Percepta©

This document is an administrative response to comments for MolDX-CDD: Percepta and does not include clinical coverage criteria. It records the public comment period (11/16/2016–01/03/2017), the notice period (01/26/2017–03/12/2017), and the LCD finalization date (03/13/2017). No indications, limitations, documentation requirements, or frequency limits for clinical services are specified in this policy.